Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: A longitudinal multiple time point study

Brain

Volumn 133, Issue 11, 2010, Pages 3315-3322

  Schott, Jonathan M ^a   Frost, Chris ^a,b   MacManus, David G ^a   Ibrahim, Fowzia ^c   Waldman, Adam D ^d   Fox, Nick C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; clinical trial design; magnetic resonance spectroscopy

Indexed keywords

CHOLINE DERIVATIVE; CHOLINESTERASE INHIBITOR; CREATINE; CREATINE PHOSPHATE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; CINGULATE GYRUS; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

AGED; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROTONS; TIME FACTORS;

EID: 78049471319     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awq208     Document Type: Article

References (35)

1. Adalsteinsson E, Sullivan EV, Kleinhans N, Spielman DM, Pfefferbaum A. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 2000; 355: 1696-7.
2. Barker PB, Hearshen DO, Boska MD. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001; 45: 765-9.
3. Barnes J, Bartlett JW, van de Pol LA, Loy CT, Scahill RI, Frost C, et al. A meta-analysis of hippocampal atrophy rates in Alzheimer's disease. Neurobiol Aging 2009; 30: 1711-23.
4. Bartha R, Smith M, Rupsingh R, Rylett J, Wells JL, Borrie MJ. High field (1)H-MRS of the hippocampus after donepezil treatment in Alzheimer disease. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 786-93.
5. Catani M, Cherubini A, Howard R, Tarducci R, Pelliccioli GP, Piccirilli M, et al. (1)H-MR spectroscopy differentiates mild cognitive impairment from normal brain aging. Neuroreport 2001; 12: 2315-7.
6. Chantal S, Labelle M, Bouchard RW, Braun CM, Boulanger Y. Correlation of regional proton magnetic resonance spectroscopic metabolic changes with cognitive deficits in mild Alzheimer disease. Arch Neurol 2002; 59: 955-62.
7. Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain 2002; 125: 2332-41.
8. Falini A, Bozzali M, Magnani G, Pero G, Gambini A, Benedetti B, et al. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment. Neuroimage 2005; 26: 1159-63.
9. Godbolt AK, Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, et al. MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology 2006; 66: 718-22.
10. Jessen F, Block W, Traber F, Keller E, Flacke S, Lamerichs R, et al. Decrease of N-acetylaspartate in the MTL correlates with cognitive decline of AD patients. Neurology 2001; 57: 930-2.
11. Jessen F, Gur O, Block W, Ende G, Frolich L, Hammen T, et al. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology 2009; 72: 1735-40.
12. Jessen F, Traeber F, Freymann K, Maier W, Schild HH, Block W. Treatment monitoring and response prediction with proton MR spectroscopy in AD. Neurology 2006; 67: 528-30.
13. Jones RS, Waldman AD. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurol Res 2004; 26: 488-95.
14. Kantarci K. 1H magnetic resonance spectroscopy in dementia. Br J Radiol 2007; 80 (Spec No. 2): S146-52.
15. Kantarci K, Jack CR Jr, Xu YC, Campeau NG, O'Brien PC, Smith GE, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: A 1H MRS study. Neurology 2000; 55: 210-7.
16. Kantarci K, Knopman DS, Dickson DW, Parisi JE, Whitwell JL, Weigand SD, et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 2008; 248: 210-20.
17. Kantarci K, Reynolds G, Petersen RC, Boeve BF, Knopman DS, Edland SD, et al. Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: comparison of 1.5 and 3T. AJNR Am J Neuroradiol 2003; 24: 843-9.
18. Kantarci K, Smith GE, Ivnik RJ, Petersen RC, Boeve BF, Knopman DS, et al. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease. J Int Neuropsychol Soc 2002a; 8: 934-42.
19. Kantarci K, Weigand SD, Petersen RC, Boeve BF, Knopman DS, Gunter J, et al. Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2007; 28: 1330-9.
20. Kantarci K, Xu Y, Shiung MM, O'Brien PC, Cha RH, Smith GE, et al. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease. Dement Geriatr Cogn Disord 2002b; 14: 198-207.
21. Krishnan KR, Charles HC, Doraiswamy PM, Mintzer J, Weisler R, Yu X, et al. Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease. Am J Psychiatry 2003; 160: 2003-11.
22. MacKay S, Ezekiel F, Di SV, Meyerhoff DJ, Gerson J, Norman D, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996; 198: 537-45.
23. Martinez-Bisbal MC, Arana E, Marti-Bonmati L, Molla E, Celda B. Cognitive impairment: classification by 1H magnetic resonance spectroscopy. Eur J Neurol 2004; 11: 187-93.
24. Modrego PJ, Pina MA, Fayed N, Diaz M. Changes in metabolite ratios after treatment with rivastigmine in Alzheimer's disease: A nonrandomised controlled trial with magnetic resonance spectroscopy. CNS Drugs 2006; 20: 867-77.
25. Olson BL, Holshouser BA, Britt W III, Mueller C, Baqai W, Patra S, et al. Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. Alzheimer Dis Assoc Disord 2008; 22: 269-77.
26. Schott JM, Crutch SJ, Frost C, Warrington EK, Rossor MN, Fox NC. Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia 2008; 46: 1732-7.
27. Schott JM, Frost C, Whitwell JL, MacManus DG, Boyes RG, Rossor MN, et al. Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials. J Neurol 2006; 253: 1147-53.
28. Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC. Measuring atrophy in Alzheimer disease: A serial MRI study over 6 and 12 months. Neurology 2005; 65: 119-24.
29. Schuff N, Amend D, Ezekiel F, Steinman SK, Tanabe J, Norman D, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease. A proton MR spectroscopic imaging and MRI study. Neurology 1997; 49: 1513-21.
30. Soher BJ, Vermathen P, Schuff N, Wiedermann D, Meyerhoff DJ, Weiner MW, et al. Short TE in vivo (1)H MR spectroscopic imaging at 1.5 T: acquisition and automated spectral analysis. Magn Reson Imaging 2000; 18: 1159-65.
31. Tkac I, Andersen P, Adriany G, Merkle H, Ugurbil K, Gruetter R. In vivo 1H NMR spectroscopy of the human brain at 7T. Magn Reson Med 2001; 46: 451-6.
32. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology 2001; 56: 592-8.
33. Wang Z, Zhao C, Yu L, Zhou W, Li K. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease. Acta Radiol 2009; 50: 312-9.
34. Zhu X, Schuff N, Kornak J, Soher B, Yaffe K, Kramer JH, et al. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging. Alzheimer Dis Assoc Disord 2006a; 20: 77-85.
35. Zhu XP, Young K, Ebel A, Soher BJ, Kaiser L, Matson G, et al. Robust analysis of short echo time (1)H MRSI of human brain. Magn Reson Med 2006b; 55: 706-11.